Naproxen Sodium (NSAID)

Product NDC
53746-191
11-digit product format
537460191
Labeler code
53746
Product ID
53746-191_9cc39ab5-450a-4e0b-948d-fdebd66c0f6f
Type
HUMAN OTC DRUG
Nonproprietary name
Naproxen Sodium
Dosage form
TABLET
Route
ORAL
Labeler
Amneal Pharmaceuticals of New York LLC
Application
ANDA079096
Marketing category
ANDA
Marketing start
2009-11-25
Substance
NAPROXEN SODIUM
Active strength
220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A079096-001NAPROXEN SODIUMNAPROXEN SODIUM220MGTABLET / ORAL2008-12-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1684e616aacf4f…
2026-08-18 06:07:402026-07A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-166a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1674a2ff9319b5…
2022-03-09 01:35 UTC2022-03A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-1687673890dc5c…
2021-03-12 10:30 UTC2021-03A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-165aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-168869cabd3fbd…
2020-11-12 02:37 UTC2020-11A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16c0c555d07b60…
2019-12-14 00:12 UTC2019-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-163f01610625f2…
2019-09-15 20:21 UTC2019-09A079096-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2008-12-16b00525d2431f…
2019-07-19 19:46 UTC2019-07A079096-001NAPROXEN SODIUMEQ 200MG BASETABLET / ORAL2008-12-16ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-166a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-161c564ffb4f44…
2023-12-20 04:57 UTC2023-12A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-169b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-163f0d92c62455…
2023-05-13 08:27 UTC2023-05A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16053a50430f4f…
2023-01-26 05:58 UTC2023-01A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-163bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-163a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A079096-001NAPROXEN SODIUM220MGTABLET / ORAL2008-12-16f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Naproxen Sodium (NSAID)
Brand name suffix
Fever Reducer/ Pain Reliever
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NAPROXEN SODIUM220 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9TN87S3A3CInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
849574Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0bb41b8c-6031-4e96-95e1-31adab811837Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53746-191-05Naproxen Sodium (NSAID)Fever Reducer/ Pain Reliever500 in 1 BOTTLETABLET50013
53746-191-08Naproxen Sodium (NSAID)Fever Reducer/ Pain Reliever8 in 1 VIALTABLET813
53746-191-24Naproxen Sodium (NSAID)Fever Reducer/ Pain Reliever24 in 1 BOTTLETABLET2413

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53746-191NAPROXEN SODIUM (NSAID) FEVER REDUCER/ PAIN RELIEVER (NAPROXEN SODIUM) TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC]13Current NDC, Legacy NDC, 3 package rows20240101_0bb41b8c-6031-4e96-95e1-31adab811837.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 31 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NAPROXENNAPROXEN SODIUMDISCOUNT DRUG MARTc1dce2e4-ad7a-4462-a775-9a5bcb2375ed2025-05-15WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
NAPROXENNAPROXEN SODIUMDISCOUNT DRUG MARTa0c67043-1e78-4eac-86e6-497b4364651a2025-05-15WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Naproxen SodiumNAPROXEN SODIUMWinCo Foods, LLC44ef3ef4-9495-4a63-92f0-f0ab19c4ec232024-12-06WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Naproxen SodiumNAPROXEN SODIUMWinCo Foods, LLC074fc2b9-743b-458e-a0c0-d5f27633bbf32024-12-06WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
All Day Pain ReliefNAPROXEN SODIUMVALU MERCHANDISERS COMPANY48059718-4e35-479c-a549-ac534d3ba8992024-12-04WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
All Day Pain ReliefNAPROXEN SODIUMVALU MERCHANDISERS COMPANY593b915f-045a-40b7-b86e-0d1cb41f2bb82024-12-04WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Lil Drug Store Pain Relief All DayNAPROXEN SODIUMLil' Drug Store Products, Inc.41d2d995-47ef-419d-8e57-ea3f9f8a9f682024-03-29WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Medique MediproxenNAPROXEN SODIUMA-S Medication Solutions2d04fef4-6a26-4df2-af90-816107e7dfe22024-02-02WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Naproxen Sodium (NSAID) Fever Reducer/ Pain RelieverNAPROXEN SODIUMAmneal Pharmaceuticals of New York LLC0bb41b8c-6031-4e96-95e1-31adab8118372023-12-31WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
ndc (product): 53746-191
All Day Pain ReliefNAPROXEN SODIUMH E B6dd54a14-67cd-4295-9bd5-1d6f8cb9316d2023-12-19WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096
Belmora FlanaxNAPROXEN SODIUMUnifirst First Aid Corporation8591ca57-04ee-5053-e053-2991aa0aa4dd2023-01-10WarningsExact identifier
application applno (ANDA): 079096
application number: ANDA079096

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
849574naproxen sodium 220 MG Oral TabletPSN0bb41b8c-6031-4e96-95e1-31adab81183713
849574naproxen sodium 220 MG Oral TabletSCD0bb41b8c-6031-4e96-95e1-31adab81183713
849574naproxen sodium 220 MG (as naproxen 200 MG) Oral TabletSY0bb41b8c-6031-4e96-95e1-31adab81183713

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53746-191-0553746019105500 TABLET in 1 BOTTLE (53746-191-05) 500 tablet2009-11-250000-00-00NoNoCurrent
53746-191-08537460191088 TABLET in 1 VIAL (53746-191-08) 8 tablet2009-11-250000-00-00NoNoCurrent
53746-191-245374601912424 TABLET in 1 BOTTLE (53746-191-24) 24 tablet2009-11-250000-00-00NoNoCurrent